The Outcomes of Surgical Pulmonary Embolectomy for Pulmonary Embolism: A Meta-Analysis

Author:

Rahouma Mohamed12ORCID,Al-Thani Shaikha1,Salem Haitham3,Mahmoud Alzahraa4,Khairallah Sherif12,Shenouda David5,Sultan Batool6,Khalil Laila7ORCID,Alomari Mohammad8ORCID,Ali Mostafa8,Makey Ian A.8,Haney John C.8ORCID,Mick Stephanie1,El-Sayed Ahmed Magdy M.89

Affiliation:

1. Cardiothoracic Surgery Department, Weill Cornell Medicine, New York, NY 10065, USA

2. Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt

3. Ain Shams University Hospital, Ain Shams University, Cairo 11517, Egypt

4. Faculty of Medicine, Beni Suef University, Beni Suef 2721562, Egypt

5. New York Institute of Technology, New York, NY 10023, USA

6. Rak Medical and Health Sciences University, Ras al Khaimah 11172, United Arab Emirates

7. Weill Cornell Medicine, Doha 24144, Qatar

8. Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA

9. Surgery Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt

Abstract

Objectives: The purpose of this study is to assess the efficacy, short- and long-term cardiovascular and non-cardiovascular mortalities and postoperative morbidities of surgical pulmonary embolectomy (SPE) for patients with massive or submassive pulmonary embolism. Methods: A comprehensive literature review was performed to identify articles reporting SPE for pulmonary embolism. The outcomes included in-hospital and long-term mortality in addition to postoperative morbidities. The random effect inverse variance method was used. Cumulative meta-analysis, leave-one-out sensitivity analysis, subgroup analysis and meta-regression were performed. Results: Among the 1949 searched studies in our systematic literature search, 78 studies met our inclusion criteria, including 6859 cases. The mean age ranged from 42 to 65 years. The percentage of males ranged from 25.6% to 86.7%. The median rate of preoperative cardiac arrest was 27.6%. The percentage of contraindications to preoperative systemic thrombolysis was 30.4%. The preoperative systemic thrombolysis use was 11.5%. The in-hospital mortality was estimated to be 21.96% (95% CI: 19.21–24.98); in-hospital mortality from direct cardiovascular causes was estimated to be 16.05% (95% CI: 12.95–19.73). With a weighted median follow-up of 3.05 years, the late cardiovascular and non-cardiovascular mortality incidence rates were 0.39 and 0.90 per person-year, respectively. The incidence of pulmonary bleeding, gastrointestinal bleeding, surgical site bleeding, non-surgical site bleeding and wound complications was 0.62%, 4.70%, 4.84%, 5.80% and 7.2%, respectively. Cumulative meta-analysis showed a decline in hospital mortality for SPE from 42.86% in 1965 to 20.56% in 2024. Meta-regression revealed that the publication year and male sex were associated with lower in-hospital mortality, while preoperative cardiac arrest, the need for inotropes or vasopressors and preoperative mechanical ventilation were associated with higher in-hospital mortality. Conclusions: This study demonstrates acceptable perioperative mortality rates and late cardiovascular and non-cardiovascular mortality in patients who undergo SPE for massive or submassive pulmonary embolism.

Publisher

MDPI AG

Reference86 articles.

1. Surgical Pulmonary Embolectomy: The Resurrection of an Almost Discarded Operation;Goldhaber;Tex. Heart Inst. J.,2013

2. 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERS);Konstantinides;Eur. Heart J.,2020

3. Pulmonary Embolism: Update on Management and Controversies;Duffett;BMJ,2020

4. Surgical Embolectomy for Acute Pulmonary Embolism: Systematic Review and Comprehensive Meta-Analyses;Kalra;Ann. Thorac. Surg.,2017

5. Wells, G.A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., and Tugwell, P. (2024, July 05). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https://web.archive.org/web/20210716121605id_/http://www3.med.unipmn.it/dispense_ebm/2009-2010/Corso%20Perfezionamento%20EBM_Faggiano/NOS_oxford.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3